WO2005002524A3 - Composes, compositions et utilisations therapeutiques de composes de type oleoylethanolamide et de modulateurs des ppar$g(a) - Google Patents
Composes, compositions et utilisations therapeutiques de composes de type oleoylethanolamide et de modulateurs des ppar$g(a) Download PDFInfo
- Publication number
- WO2005002524A3 WO2005002524A3 PCT/US2004/021394 US2004021394W WO2005002524A3 WO 2005002524 A3 WO2005002524 A3 WO 2005002524A3 US 2004021394 W US2004021394 W US 2004021394W WO 2005002524 A3 WO2005002524 A3 WO 2005002524A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- ppara
- oea
- oleoylethanolamide
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48506203P | 2003-07-02 | 2003-07-02 | |
US60/485,062 | 2003-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005002524A2 WO2005002524A2 (fr) | 2005-01-13 |
WO2005002524A3 true WO2005002524A3 (fr) | 2005-04-28 |
Family
ID=33564043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/021394 WO2005002524A2 (fr) | 2003-07-02 | 2004-07-01 | Composes, compositions et utilisations therapeutiques de composes de type oleoylethanolamide et de modulateurs des ppar$g(a) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005002524A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7083933B1 (en) | 2003-05-09 | 2006-08-01 | Prosidion Limited | Methods for identification of modulators of OSGPR116 activity |
US20090099240A1 (en) * | 2006-10-02 | 2009-04-16 | N.V. Organon | Methods for treating energy metabolism disorders by inhibiting fatty acid amide hydrolase activity |
WO2023170552A1 (fr) * | 2022-03-07 | 2023-09-14 | Clearmind Medicine Inc. | Compositions comprenant du meai et des n-acylethanolamines et leurs utilisations |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679667A (en) * | 1992-04-24 | 1997-10-21 | Lifegroup S.P.A. | Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve |
US20030041340A1 (en) * | 2001-07-31 | 2003-02-27 | Cravatt Benjamin F. | Animal model for fatty acid amide-related neurobehaviors |
-
2004
- 2004-07-01 WO PCT/US2004/021394 patent/WO2005002524A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679667A (en) * | 1992-04-24 | 1997-10-21 | Lifegroup S.P.A. | Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve |
US20030041340A1 (en) * | 2001-07-31 | 2003-02-27 | Cravatt Benjamin F. | Animal model for fatty acid amide-related neurobehaviors |
Also Published As
Publication number | Publication date |
---|---|
WO2005002524A2 (fr) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007269070B2 (en) | Bicyclic heteroaryl inhibitors of PDE4 | |
MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
KR20190009369A (ko) | 3-옥소-2,6-디페닐-2,3-디히드로피리다진-4-카르복스아미드 | |
MX2007007220A (es) | Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos. | |
MY133406A (en) | 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament | |
UA84048C2 (ru) | Производные сульфонамида для лечения заболеваний, способ их получения (варианты), фармацевтическая композиция на их основе | |
MA28438B1 (fr) | Derives azabicyclo (3.1.0) hexane utiles comme modulateurs des recepteurs d3 de la dopamine | |
MA30355B1 (fr) | Derives d'azabicyclo [3. 1. 0] hexyle utilises comme modulateurs des recepteurs de la dopamine d3 | |
MX2007012936A (es) | Derivados de dihidrobenzofurano y usos de los mismos. | |
NO20071660L (no) | Nye pyridinonderivater og deres anvendelse som positive allosteriske modulatorer av MGLUR2-reseptorer | |
CA2565660A1 (fr) | Composes aryl- ou heteroarylamides ortho-substitues | |
WO2004089366A8 (fr) | Composes bicycliques comme antagonistes du recepteur nr2b | |
EP1725536B8 (fr) | Derives de l'imidazoline presentant une activite antagoniste cb1 | |
CN105001165A (zh) | 取代的二氨基嘧啶其组合物,和用其治疗的方法 | |
IL163629A0 (en) | Glutaminyl derivatives and pharmaceutical compositions containing the same | |
MXPA05012840A (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades. | |
MA53124B1 (fr) | Agents de dégradation sélectifs des récepteurs des oestrogènes | |
SE0300119D0 (sv) | Novel compounds | |
EP2202222A3 (fr) | Dérivés d'indène, leur préparation et leur utilisation en tant que médicaments | |
WO2008151460A3 (fr) | Composés de refroidissement | |
MA28742B1 (fr) | Derives de pyrido-pyrimidine, leur preparation, leur application en therapeutique | |
MXPA05012329A (es) | Compuestos utiles para el tratamiento de enfermedades. | |
MA31895B1 (fr) | (alkyl en c<sb>2</sb>-c<sb>5</sb>) imidazole - bisphosphonates | |
RU2003134629A (ru) | Соединения цефема | |
WO2005002524A3 (fr) | Composes, compositions et utilisations therapeutiques de composes de type oleoylethanolamide et de modulateurs des ppar$g(a) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |